The FDA approved the first human clinical trial using embryonic stem cells to replace damaged cells in spinal cords.
This announcement comes just days after Barack Obama started his term as President.
For the last eight years, stem cell research was stymied by a federal funding ban that prevented scientists to develop new stem cell lines using human embryos.
